NEXXALFI Trademark

Trademark Overview

On Friday, July 25, 2025, a trademark application was filed for NEXXALFI with the United States Patent and Trademark Office. The USPTO has given the NEXXALFI trademark a serial number of 99302929. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, December 22, 2025. This trademark is owned by Genzyme Corporation. The NEXXALFI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of somatostatin-expressing neuroendocrine tumors; Pharmaceutical preparations for the treatment and prevention of oncological, gastrointestinal, and hepatological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of rare oncological, gastrointestinal, and hepatological diseases and disorders; Pharmaceutical products for the prevention and treatment of cancer; Radiopharmaceutical preparations for the treatment of oncological, gastrointestinal, and hepatological diseases and disorders
nexxalfi

General Information

Serial Number99302929
Word MarkNEXXALFI
Filing DateFriday, July 25, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, December 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 13, 2026

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of somatostatin-expressing neuroendocrine tumors; Pharmaceutical preparations for the treatment and prevention of oncological, gastrointestinal, and hepatological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of rare oncological, gastrointestinal, and hepatological diseases and disorders; Pharmaceutical products for the prevention and treatment of cancer; Radiopharmaceutical preparations for the treatment of oncological, gastrointestinal, and hepatological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 25, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenzyme Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141

Trademark Events

Event DateEvent Description
Friday, July 25, 2025NEW APPLICATION ENTERED
Friday, July 25, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 25, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, August 6, 2025TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, August 18, 2025ASSIGNED TO LIE
Wednesday, August 20, 2025PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, December 11, 2025ASSIGNED TO EXAMINER
Thursday, December 11, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

nexxalfi treatment pharmaceutical prevention preparations gastrointestinal hepatological diseases disorders oncological products